Performance evaluation of the MAGLUMI Hepatitis B virus surface antigen chemiluminescence immunoassay
A highly sensitive and reliable Hepatitis B virus surface antigen (HBsAg) measurement is essential to universal screening, timely diagnosis, and management of Hepatitis B virus (HBV) infection. This study aimed to evaluate the performance of MAGLUMI HBsAg chemiluminescence immunoassay (CLIA). MAGLUM...
Uložené v:
| Vydané v: | Journal of medical virology Ročník 96; číslo 7; s. e29817 - n/a |
|---|---|
| Hlavní autori: | , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
United States
Wiley Subscription Services, Inc
01.07.2024
|
| Predmet: | |
| ISSN: | 0146-6615, 1096-9071, 1096-9071 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | A highly sensitive and reliable Hepatitis B virus surface antigen (HBsAg) measurement is essential to universal screening, timely diagnosis, and management of Hepatitis B virus (HBV) infection. This study aimed to evaluate the performance of MAGLUMI HBsAg chemiluminescence immunoassay (CLIA). MAGLUMI HBsAg (CLIA) was compared against ARCHITECT HBsAg. 411 HBsAg positive samples, including different stages of infection, genotypes, subtypes, mutants, and 30 seroconversion panels were tested to evaluate diagnostic sensitivity. Diagnostic specificity was evaluated by testing 205 hospitalized samples and 5101 blood donor samples. Precision, limit of blank (LoB), limit of detection (LoD), and linearity were also verified. The diagnostic sensitivity of the MAGLUMI HBsAg (CLIA) was 100% with better seroconversion sensitivity than ARCHITECT HBsAg. The MAGLUMI HBsAg (CLIA) has optimal detection efficacy for HBV subgenotypes samples. The analytical sensitivity is 0.039 IU/mL. The initial diagnostic specificity is 99.63% on blood donors and 96.59% on hospitalized samples. The verification data demonstrated high repeatability, a LoB of 0.02 IU/mL, LoD of 0.05 IU/mL and an excellent linearity of 0.050–250 IU/mL (R2 = 0.9946). The MAGLUMI HBsAg (CLIA) is proved a highly sensitive and reliable assay with optimal subgenotype detection efficacy. |
|---|---|
| AbstractList | A highly sensitive and reliable Hepatitis B virus surface antigen (HBsAg) measurement is essential to universal screening, timely diagnosis, and management of Hepatitis B virus (HBV) infection. This study aimed to evaluate the performance of MAGLUMI HBsAg chemiluminescence immunoassay (CLIA). MAGLUMI HBsAg (CLIA) was compared against ARCHITECT HBsAg. 411 HBsAg positive samples, including different stages of infection, genotypes, subtypes, mutants, and 30 seroconversion panels were tested to evaluate diagnostic sensitivity. Diagnostic specificity was evaluated by testing 205 hospitalized samples and 5101 blood donor samples. Precision, limit of blank (LoB), limit of detection (LoD), and linearity were also verified. The diagnostic sensitivity of the MAGLUMI HBsAg (CLIA) was 100% with better seroconversion sensitivity than ARCHITECT HBsAg. The MAGLUMI HBsAg (CLIA) has optimal detection efficacy for HBV subgenotypes samples. The analytical sensitivity is 0.039 IU/mL. The initial diagnostic specificity is 99.63% on blood donors and 96.59% on hospitalized samples. The verification data demonstrated high repeatability, a LoB of 0.02 IU/mL, LoD of 0.05 IU/mL and an excellent linearity of 0.050–250 IU/mL (R2 = 0.9946). The MAGLUMI HBsAg (CLIA) is proved a highly sensitive and reliable assay with optimal subgenotype detection efficacy. A highly sensitive and reliable Hepatitis B virus surface antigen (HBsAg) measurement is essential to universal screening, timely diagnosis, and management of Hepatitis B virus (HBV) infection. This study aimed to evaluate the performance of MAGLUMI HBsAg chemiluminescence immunoassay (CLIA). MAGLUMI HBsAg (CLIA) was compared against ARCHITECT HBsAg. 411 HBsAg positive samples, including different stages of infection, genotypes, subtypes, mutants, and 30 seroconversion panels were tested to evaluate diagnostic sensitivity. Diagnostic specificity was evaluated by testing 205 hospitalized samples and 5101 blood donor samples. Precision, limit of blank (LoB), limit of detection (LoD), and linearity were also verified. The diagnostic sensitivity of the MAGLUMI HBsAg (CLIA) was 100% with better seroconversion sensitivity than ARCHITECT HBsAg. The MAGLUMI HBsAg (CLIA) has optimal detection efficacy for HBV subgenotypes samples. The analytical sensitivity is 0.039 IU/mL. The initial diagnostic specificity is 99.63% on blood donors and 96.59% on hospitalized samples. The verification data demonstrated high repeatability, a LoB of 0.02 IU/mL, LoD of 0.05 IU/mL and an excellent linearity of 0.050-250 IU/mL (R = 0.9946). The MAGLUMI HBsAg (CLIA) is proved a highly sensitive and reliable assay with optimal subgenotype detection efficacy. A highly sensitive and reliable Hepatitis B virus surface antigen (HBsAg) measurement is essential to universal screening, timely diagnosis, and management of Hepatitis B virus (HBV) infection. This study aimed to evaluate the performance of MAGLUMI HBsAg chemiluminescence immunoassay (CLIA). MAGLUMI HBsAg (CLIA) was compared against ARCHITECT HBsAg. 411 HBsAg positive samples, including different stages of infection, genotypes, subtypes, mutants, and 30 seroconversion panels were tested to evaluate diagnostic sensitivity. Diagnostic specificity was evaluated by testing 205 hospitalized samples and 5101 blood donor samples. Precision, limit of blank (LoB), limit of detection (LoD), and linearity were also verified. The diagnostic sensitivity of the MAGLUMI HBsAg (CLIA) was 100% with better seroconversion sensitivity than ARCHITECT HBsAg. The MAGLUMI HBsAg (CLIA) has optimal detection efficacy for HBV subgenotypes samples. The analytical sensitivity is 0.039 IU/mL. The initial diagnostic specificity is 99.63% on blood donors and 96.59% on hospitalized samples. The verification data demonstrated high repeatability, a LoB of 0.02 IU/mL, LoD of 0.05 IU/mL and an excellent linearity of 0.050-250 IU/mL (R2 = 0.9946). The MAGLUMI HBsAg (CLIA) is proved a highly sensitive and reliable assay with optimal subgenotype detection efficacy.A highly sensitive and reliable Hepatitis B virus surface antigen (HBsAg) measurement is essential to universal screening, timely diagnosis, and management of Hepatitis B virus (HBV) infection. This study aimed to evaluate the performance of MAGLUMI HBsAg chemiluminescence immunoassay (CLIA). MAGLUMI HBsAg (CLIA) was compared against ARCHITECT HBsAg. 411 HBsAg positive samples, including different stages of infection, genotypes, subtypes, mutants, and 30 seroconversion panels were tested to evaluate diagnostic sensitivity. Diagnostic specificity was evaluated by testing 205 hospitalized samples and 5101 blood donor samples. Precision, limit of blank (LoB), limit of detection (LoD), and linearity were also verified. The diagnostic sensitivity of the MAGLUMI HBsAg (CLIA) was 100% with better seroconversion sensitivity than ARCHITECT HBsAg. The MAGLUMI HBsAg (CLIA) has optimal detection efficacy for HBV subgenotypes samples. The analytical sensitivity is 0.039 IU/mL. The initial diagnostic specificity is 99.63% on blood donors and 96.59% on hospitalized samples. The verification data demonstrated high repeatability, a LoB of 0.02 IU/mL, LoD of 0.05 IU/mL and an excellent linearity of 0.050-250 IU/mL (R2 = 0.9946). The MAGLUMI HBsAg (CLIA) is proved a highly sensitive and reliable assay with optimal subgenotype detection efficacy. A highly sensitive and reliable Hepatitis B virus surface antigen (HBsAg) measurement is essential to universal screening, timely diagnosis, and management of Hepatitis B virus (HBV) infection. This study aimed to evaluate the performance of MAGLUMI HBsAg chemiluminescence immunoassay (CLIA). MAGLUMI HBsAg (CLIA) was compared against ARCHITECT HBsAg. 411 HBsAg positive samples, including different stages of infection, genotypes, subtypes, mutants, and 30 seroconversion panels were tested to evaluate diagnostic sensitivity. Diagnostic specificity was evaluated by testing 205 hospitalized samples and 5101 blood donor samples. Precision, limit of blank (LoB), limit of detection (LoD), and linearity were also verified. The diagnostic sensitivity of the MAGLUMI HBsAg (CLIA) was 100% with better seroconversion sensitivity than ARCHITECT HBsAg. The MAGLUMI HBsAg (CLIA) has optimal detection efficacy for HBV subgenotypes samples. The analytical sensitivity is 0.039 IU/mL. The initial diagnostic specificity is 99.63% on blood donors and 96.59% on hospitalized samples. The verification data demonstrated high repeatability, a LoB of 0.02 IU/mL, LoD of 0.05 IU/mL and an excellent linearity of 0.050–250 IU/mL ( R 2 = 0.9946). The MAGLUMI HBsAg (CLIA) is proved a highly sensitive and reliable assay with optimal subgenotype detection efficacy. |
| Author | Shao, Lijia Yin, Jun Li, Tinghua Shi, Min Shen, Lihong Feng, Shengchun Li, Weiting Fang, Zhonggang Zhang, Yun |
| Author_xml | – sequence: 1 givenname: Lihong surname: Shen fullname: Shen, Lihong organization: Zhejiang University School of Medicine – sequence: 2 givenname: Yun surname: Zhang fullname: Zhang, Yun organization: Shenzhen New Industries Biomedical Engineering Co. Ltd – sequence: 3 givenname: Min surname: Shi fullname: Shi, Min organization: Shenzhen New Industries Biomedical Engineering Co. Ltd – sequence: 4 givenname: Lijia surname: Shao fullname: Shao, Lijia organization: Zhejiang University School of Medicine – sequence: 5 givenname: Shengchun surname: Feng fullname: Feng, Shengchun organization: Zhejiang University School of Medicine – sequence: 6 givenname: Weiting surname: Li fullname: Li, Weiting organization: Shenzhen New Industries Biomedical Engineering Co. Ltd – sequence: 7 givenname: Zhonggang surname: Fang fullname: Fang, Zhonggang organization: Shenzhen New Industries Biomedical Engineering Co. Ltd – sequence: 8 givenname: Jun surname: Yin fullname: Yin, Jun organization: Shenzhen New Industries Biomedical Engineering Co. Ltd – sequence: 9 givenname: Tinghua orcidid: 0009-0005-2334-2139 surname: Li fullname: Li, Tinghua email: litinghua@snibe.cn organization: Shenzhen New Industries Biomedical Engineering Co. Ltd |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39034740$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kU9vEzEUxC1URNPCgS-ALHGBw7bP9v7xHktV2qJEcGh7tWznLXW0toO9myrfnk2TXio4PenpN6PRzAk5CjEgIR8ZnDEAfr7ymzPeSta8ITMGbV200LAjMgNW1kVds-qYnOS8AgDZcv6OHIsWRNmUMCP4C1MXk9fBIsWN7kc9uBho7OjwiHRxcT2_X9zSG1xP_8Fl-o1uXBozzWPq9KTRYXC_MVD7iN71o3cBs8Wdm_N-DFHnrLfvydtO9xk_HO4puf9-dXd5U8x_Xt9eXswLKyrRFLwBMKUQKGxlq1Z01krTGM0bIw2vNOeMG6mXumqxakBDV9aslXJZGim72ohT8mXvu07xz4h5UN5NafpeB4xjVgKk4Kxikk_o51foKo4pTOl2VMUBSlZO1KcDNRqPS7VOzuu0VS8FTsD5HrAp5pywU9YNzxUOSbteMVC7idQ0kXqeaFJ8faV4Mf0Xe3B_cj1u_w-qH4uHveIvNQyfqw |
| CitedBy_id | crossref_primary_10_1016_j_trac_2024_117985 |
| Cites_doi | 10.3748/wjg.v20.i30.10395 10.3201/eid1203.050038 10.4254/wjh.v6.i12.860 10.1016/S0140-6736(22)01468-4 10.1016/j.jhep.2019.03.034 10.25259/GJMPBU_77_2022 10.1038/s41598-019-56015-8 10.1111/hepr.13602 10.1128/jcm.02204-21 10.1007/978-3-030-03502-0_9 10.1002/hep.22881 10.7150/ijbs.55724 10.1001/jamanetworkopen.2022.16485 10.1007/s005350300043 10.15585/mmwr.rr7201a1 10.1002/hep.29800 10.3748/wjg.v24.i31.3488 10.1016/j.jhep.2011.06.006 10.1016/j.gastha.2023.01.017 10.1016/j.lanwpc.2022.100428 10.1371/journal.pone.0272920 10.1002/hep.31991 10.1016/S2468-1253(22)00201-1 10.3748/wjg.15.3099 10.1016/j.clinre.2023.102180 10.1002/hep.21347 10.3390/genes9100495 10.4254/wjh.v7.i27.2729 10.1016/j.jcv.2020.104507 10.3389/fmicb.2021.678537 10.1038/s41575-023-00760-9 10.3390/v13061124 10.3390/v14071504 10.1016/j.jcv.2013.06.011 10.1016/S1473-3099(16)30204-3 10.1016/j.heliyon.2019.e02556 |
| ContentType | Journal Article |
| Copyright | 2024 Wiley Periodicals LLC. |
| Copyright_xml | – notice: 2024 Wiley Periodicals LLC. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QL 7TK 7U9 8FD C1K FR3 H94 K9. M7N P64 RC3 7X8 |
| DOI | 10.1002/jmv.29817 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Bacteriology Abstracts (Microbiology B) Neurosciences Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Genetics Abstracts Virology and AIDS Abstracts Technology Research Database Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Engineering Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic CrossRef Genetics Abstracts |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1096-9071 |
| EndPage | n/a |
| ExternalDocumentID | 39034740 10_1002_jmv_29817 JMV29817 |
| Genre | researchArticle Research Support, Non-U.S. Gov't Evaluation Study Journal Article |
| GrantInformation_xml | – fundername: Jinhua Science and Technology Bureau funderid: 2021‐4‐009 – fundername: Jinhua Central Hospital funderid: JY2021‐1‐04 – fundername: Jinhua Central Hospital grantid: JY2021-1-04 – fundername: Jinhua Science and Technology Bureau grantid: 2021-4-009 |
| GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 31~ 33P 3O- 3SF 3WU 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFNX AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHMBA AI. AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBD EBS ECGQY EJD ELTNK EMOBN F00 F01 F04 F5P FEDTE FUBAC G-S G.N GNP GODZA H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M JPC KBYEO KQQ L7B LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M65 MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RGB RIWAO RJQFR ROL RWI RX1 RYL SAMSI SUPJJ SV3 TEORI TUS UB1 V2E VH1 W8V W99 WBKPD WHG WIB WIH WIJ WIK WJL WNSPC WOHZO WQJ WRC WUP WXI WXSBR WYISQ X7M XG1 XPP XV2 ZGI ZXP ZZTAW ~IA ~KM ~WT AAMMB AAYXX AEFGJ AEYWJ AGHNM AGQPQ AGXDD AGYGG AIDQK AIDYY AIQQE CITATION O8X CGR CUY CVF ECM EIF NPM 7QL 7TK 7U9 8FD C1K FR3 H94 K9. M7N P64 RC3 7X8 |
| ID | FETCH-LOGICAL-c3537-2700b433e3c5c593fcc8b7ba27b8b25a2212b8ada59e570a0f461988d4b88f6b3 |
| IEDL.DBID | DRFUL |
| ISICitedReferencesCount | 1 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001279358500021&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0146-6615 1096-9071 |
| IngestDate | Fri Jul 11 15:33:54 EDT 2025 Sat Nov 29 14:43:08 EST 2025 Wed Sep 24 03:03:57 EDT 2025 Tue Nov 18 22:23:15 EST 2025 Sat Nov 29 03:41:01 EST 2025 Wed Jan 22 17:18:02 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 7 |
| Keywords | performance evaluation Hepatitis B virus surface antigen Hepatitis B virus surface antigen sensitivity Hepatitis B virus surface antigen subgenotypes MAGLUMI immunoassay |
| Language | English |
| License | 2024 Wiley Periodicals LLC. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c3537-2700b433e3c5c593fcc8b7ba27b8b25a2212b8ada59e570a0f461988d4b88f6b3 |
| Notes | Lihong Shen, Yun Zhang, and Min Shi contributed equally to this work and share first authorship. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 |
| ORCID | 0009-0005-2334-2139 |
| PMID | 39034740 |
| PQID | 3085200414 |
| PQPubID | 105515 |
| PageCount | 11 |
| ParticipantIDs | proquest_miscellaneous_3083215182 proquest_journals_3085200414 pubmed_primary_39034740 crossref_citationtrail_10_1002_jmv_29817 crossref_primary_10_1002_jmv_29817 wiley_primary_10_1002_jmv_29817_JMV29817 |
| PublicationCentury | 2000 |
| PublicationDate | July 2024 2024-07-00 20240701 |
| PublicationDateYYYYMMDD | 2024-07-01 |
| PublicationDate_xml | – month: 07 year: 2024 text: July 2024 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: London |
| PublicationTitle | Journal of medical virology |
| PublicationTitleAlternate | J Med Virol |
| PublicationYear | 2024 |
| Publisher | Wiley Subscription Services, Inc |
| Publisher_xml | – name: Wiley Subscription Services, Inc |
| References | 2019; 9 2019; 71 2019; 5 2015; 3 2006; 12 2023; 18 2023; 401 2011; 55 2003; 38 2020; 129 2023; 2 2022; 22 2018; 67 2021; 74 2016; 16 2015; 7 2021; 51 2009; 49 2018; 24 2014; 20 2023; 20 2021; 13 2018; 9 2013; 58 2023; 47 2021; 12 2022; 60 2022; 5 2006; 44 2022; 7 2021; 17 2022; 14 2014; 6 2019; 177 2023; 72 2009; 15 2022; 17 e_1_2_10_23_1 e_1_2_10_24_1 e_1_2_10_21_1 e_1_2_10_22_1 e_1_2_10_20_1 e_1_2_10_40_1 e_1_2_10_2_1 e_1_2_10_4_1 e_1_2_10_18_1 e_1_2_10_3_1 e_1_2_10_19_1 e_1_2_10_6_1 e_1_2_10_16_1 e_1_2_10_39_1 e_1_2_10_5_1 e_1_2_10_17_1 e_1_2_10_38_1 e_1_2_10_8_1 e_1_2_10_14_1 e_1_2_10_37_1 e_1_2_10_7_1 e_1_2_10_15_1 e_1_2_10_36_1 e_1_2_10_12_1 e_1_2_10_35_1 e_1_2_10_9_1 e_1_2_10_13_1 e_1_2_10_34_1 e_1_2_10_10_1 e_1_2_10_33_1 e_1_2_10_11_1 e_1_2_10_31_1 e_1_2_10_30_1 Gonzalez J (e_1_2_10_32_1) 2015; 3 e_1_2_10_29_1 e_1_2_10_27_1 e_1_2_10_28_1 e_1_2_10_25_1 e_1_2_10_26_1 |
| References_xml | – volume: 20 start-page: 524 year: 2023 end-page: 537 article-title: Global burden of hepatitis B virus: current status, missed opportunities and a call for action publication-title: Nat Rev Gastroenterol Hepatol – volume: 17 year: 2022 article-title: Global epidemiology of occult hepatitis B virus infections in blood donors, a systematic review and meta‐analysis publication-title: PLoS One – volume: 55 start-page: 1121 year: 2011 end-page: 1131 article-title: Hepatitis B surface antigen quantification: why and how to use it in 2011—a core group report publication-title: J Hepatol – volume: 5 year: 2019 article-title: A systematic genotype and subgenotype re‐ranking of hepatitis B virus under a novel classification standard publication-title: Heliyon – volume: 38 start-page: 244 year: 2003 end-page: 253 article-title: Molecular analysis of antigenicity and immunogenicity of a vaccine‐induced escape mutant of hepatitis B virus publication-title: J Gastroenterol – volume: 3 start-page: 63 year: 2015 end-page: 69 article-title: Diagnosis and management of occult, hepatitis B virus infection: a short revive publication-title: Hepatology – volume: 177 start-page: 231 year: 2019 end-page: 250 article-title: HIV‐HBV and HIV‐HCV coinfection and liver cancer development publication-title: Cancer Treat Res – volume: 24 start-page: 3488 year: 2018 end-page: 3499 article-title: Hepatitis B virus infection: defective surface antigen expression and pathogenesis publication-title: World J Gastroenterol – volume: 58 start-page: 47 year: 2013 end-page: 53 article-title: Performance of hepatitis B surface antigen tests with the first WHO international hepatitis B virus genotype reference panel publication-title: J Clin Virol – volume: 60 year: 2022 article-title: Detection of the hepatitis B surface antigen in patients with occult hepatitis B by use of an assay with enhanced sensitivity publication-title: J Clin Microbiol – volume: 14 year: 2022 article-title: Occult hepatitis B virus infection: an update publication-title: Viruses – volume: 6 start-page: 860 year: 2014 end-page: 869 article-title: Occult hepatitis B virus infection publication-title: World J Hepatol – volume: 129 year: 2020 article-title: The contribution of more sensitive hepatitis B surface antigen assays to detecting and monitoring hepatitis B infection publication-title: J Clin Virol – volume: 20 start-page: 10395 year: 2014 end-page: 10404 article-title: Natural history of chronic hepatitis B: phases in a complex relationship publication-title: World J Gastroenterol – volume: 44 start-page: 521 year: 2006 end-page: 526 article-title: Global challenges in liver disease publication-title: Hepatology – volume: 401 start-page: 1039 year: 2023 end-page: 1052 article-title: Hepatitis B publication-title: The Lancet – volume: 9 year: 2018 article-title: The global hepatitis B virus genotype distribution approximated from available genotyping data publication-title: Genes – volume: 2 start-page: 467 year: 2023 end-page: 474 article-title: The coexistence of hepatitis B surface antigen and anti‐HBs in patients with chronic HBV infection: prevalence and related factors publication-title: Gastro Hep Advances – volume: 49 start-page: S13 year: 2009 end-page: S21 article-title: Hepatitis B: the virus and disease publication-title: Hepatology – volume: 12 start-page: 198 year: 2006 end-page: 203 article-title: Detecting hepatitis B surface antigen mutants publication-title: Emerging Infect Dis – volume: 5 year: 2022 article-title: Association of coexistent hepatitis B surface antigen and antibody with severe liver fibrosis and cirrhosis in treatment‐naive patients with chronic hepatitis B publication-title: JAMA Netw. Open – volume: 15 start-page: 3099 year: 2009 end-page: 3105 article-title: Molecular characteristics and stages of chronic hepatitis B virus infection publication-title: World J Gastroenterol – volume: 13 year: 2021 article-title: Envelope proteins of hepatitis B virus: molecular biology and involvement in carcinogenesis publication-title: Viruses – volume: 67 start-page: 1560 year: 2018 end-page: 1599 article-title: Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance publication-title: Hepatology – volume: 18 start-page: 1 year: 2023 article-title: Enzyme‐linked immunosorbent assay versus chemiluminescent immunoassay: a general overview publication-title: Glob J Med Pharm Biomed Update – volume: 17 start-page: 1125 year: 2021 end-page: 1137 article-title: Paradoxical HBsAg and anti‐HBs coexistence among chronic HBV infections: causes and consequences publication-title: Int J Biol Sci – volume: 74 start-page: 2353 year: 2021 end-page: 2365 article-title: Prevalence of HBV infection, vaccine‐Induced immunity, and susceptibility among at‐risk populations: US households, 2013‐2018 publication-title: Hepatology – volume: 7 start-page: 932 year: 2022 end-page: 942 article-title: Prevalence of occult hepatitis B virus infection in adults: a systematic review and meta‐analysis publication-title: Lancet Gastroenterol Hepatol – volume: 47 year: 2023 article-title: A review of epidemiology and clinical relevance of hepatitis B virus genotypes and subgenotypes publication-title: Clin. Res. Hepatol. Gastroenterol – volume: 72 start-page: 1 year: 2023 end-page: 25 article-title: Screening and testing for hepatitis B virus infection: CDC recommendations—United States, 2023 publication-title: MMWR Recomm Rep – volume: 71 start-page: 397 year: 2019 end-page: 408 article-title: Update of the statements on biology and clinical impact of occult hepatitis B virus infection publication-title: J Hepatol – volume: 22 year: 2022 article-title: Burden of chronic hepatitis B and C infections in 2015 and future trends in Japan: A simulation study publication-title: The Lancet Regional Health Western Pacific – volume: 16 start-page: 1399 year: 2016 end-page: 1408 article-title: Requirements for global elimination of hepatitis B: a modelling study publication-title: Lancet Infect Dis – volume: 9 year: 2019 article-title: Long‐term outcomes of HBsAg/anti‐HBs double‐positive versus HBsAg single‐positive patients with chronic hepatitis B publication-title: Sci Rep – volume: 51 start-page: 426 year: 2021 end-page: 435 article-title: Potential of ultra‐highly sensitive immunoassays for hepatitis B surface and core‐related antigens in patients with or without development of hepatocellular carcinoma after hepatitis B surface antigen seroclearance publication-title: Hepatol Res – volume: 12 year: 2021 article-title: Persistence of hepatitis B virus infection: a multi‐faceted player for hepatocarcinogenesis publication-title: Front Microbiol – volume: 7 start-page: 2729 year: 2015 end-page: 2739 article-title: Clinical significance of hepatitis B surface antigen mutants publication-title: World J Hepatol – ident: e_1_2_10_16_1 doi: 10.3748/wjg.v20.i30.10395 – ident: e_1_2_10_25_1 doi: 10.3201/eid1203.050038 – ident: e_1_2_10_31_1 doi: 10.4254/wjh.v6.i12.860 – ident: e_1_2_10_5_1 doi: 10.1016/S0140-6736(22)01468-4 – ident: e_1_2_10_28_1 doi: 10.1016/j.jhep.2019.03.034 – ident: e_1_2_10_40_1 doi: 10.25259/GJMPBU_77_2022 – ident: e_1_2_10_17_1 doi: 10.1038/s41598-019-56015-8 – ident: e_1_2_10_35_1 doi: 10.1111/hepr.13602 – ident: e_1_2_10_36_1 doi: 10.1128/jcm.02204-21 – ident: e_1_2_10_39_1 doi: 10.1007/978-3-030-03502-0_9 – ident: e_1_2_10_13_1 doi: 10.1002/hep.22881 – ident: e_1_2_10_12_1 doi: 10.7150/ijbs.55724 – ident: e_1_2_10_18_1 doi: 10.1001/jamanetworkopen.2022.16485 – ident: e_1_2_10_26_1 doi: 10.1007/s005350300043 – ident: e_1_2_10_8_1 doi: 10.15585/mmwr.rr7201a1 – ident: e_1_2_10_10_1 doi: 10.1002/hep.29800 – ident: e_1_2_10_11_1 doi: 10.3748/wjg.v24.i31.3488 – ident: e_1_2_10_20_1 doi: 10.1016/j.jhep.2011.06.006 – ident: e_1_2_10_19_1 doi: 10.1016/j.gastha.2023.01.017 – ident: e_1_2_10_2_1 doi: 10.1016/j.lanwpc.2022.100428 – ident: e_1_2_10_33_1 doi: 10.1371/journal.pone.0272920 – ident: e_1_2_10_4_1 doi: 10.1002/hep.31991 – ident: e_1_2_10_30_1 doi: 10.1016/S2468-1253(22)00201-1 – ident: e_1_2_10_15_1 doi: 10.3748/wjg.15.3099 – ident: e_1_2_10_24_1 doi: 10.1016/j.clinre.2023.102180 – ident: e_1_2_10_38_1 doi: 10.1002/hep.21347 – ident: e_1_2_10_22_1 doi: 10.3390/genes9100495 – ident: e_1_2_10_37_1 – ident: e_1_2_10_27_1 doi: 10.4254/wjh.v7.i27.2729 – volume: 3 start-page: 63 year: 2015 ident: e_1_2_10_32_1 article-title: Diagnosis and management of occult, hepatitis B virus infection: a short revive publication-title: Hepatology – ident: e_1_2_10_34_1 doi: 10.1016/j.jcv.2020.104507 – ident: e_1_2_10_6_1 – ident: e_1_2_10_14_1 doi: 10.3389/fmicb.2021.678537 – ident: e_1_2_10_3_1 doi: 10.1038/s41575-023-00760-9 – ident: e_1_2_10_9_1 doi: 10.3390/v13061124 – ident: e_1_2_10_29_1 doi: 10.3390/v14071504 – ident: e_1_2_10_21_1 doi: 10.1016/j.jcv.2013.06.011 – ident: e_1_2_10_7_1 doi: 10.1016/S1473-3099(16)30204-3 – ident: e_1_2_10_23_1 doi: 10.1016/j.heliyon.2019.e02556 |
| SSID | ssj0008922 |
| Score | 2.4285014 |
| Snippet | A highly sensitive and reliable Hepatitis B virus surface antigen (HBsAg) measurement is essential to universal screening, timely diagnosis, and management of... |
| SourceID | proquest pubmed crossref wiley |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | e29817 |
| SubjectTerms | Adolescent Adult Aged Antigens Blood Blood donors Chemiluminescence Diagnostic systems Effectiveness Female Genotype Genotypes Hepatitis Hepatitis B Hepatitis B - blood Hepatitis B - diagnosis Hepatitis B surface antigen Hepatitis B Surface Antigens - blood Hepatitis B Surface Antigens - immunology Hepatitis B virus - genetics Hepatitis B virus - immunology Hepatitis B virus - isolation & purification Hepatitis B virus surface antigen Hepatitis B virus surface antigen sensitivity Hepatitis B virus surface antigen subgenotypes Humans Immunoassay Immunoassay - methods Immunoassay - standards Linearity Luminescent Measurements - methods MAGLUMI Male Middle Aged Performance evaluation Reproducibility of Results Sensitivity analysis Sensitivity and Specificity Seroconversion Viruses Young Adult |
| Title | Performance evaluation of the MAGLUMI Hepatitis B virus surface antigen chemiluminescence immunoassay |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjmv.29817 https://www.ncbi.nlm.nih.gov/pubmed/39034740 https://www.proquest.com/docview/3085200414 https://www.proquest.com/docview/3083215182 |
| Volume | 96 |
| WOSCitedRecordID | wos001279358500021&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library Full Collection 2020 customDbUrl: eissn: 1096-9071 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0008922 issn: 0146-6615 databaseCode: DRFUL dateStart: 19960101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3PT9swFH6CgqZd2MbGKGPIoB12yZracW1rp27QsalFaFpRb5Ht2FIRtKhpK_Hf85ykqdCGNIlbpDzLlt-vL_F7nwE-ZZnPuA-tW8qIKOlIHZmYu4h2jG_7DFNiUfJ_1RcXF3I0Upcb8HXVC1PyQ9Q_3IJnFPE6OLg2eWtNGnp9u_xClWyLTdiiaLdJA7ZOf_eG_ToQS1UeImAwiDAN8RWxUExb9eDH6egvjPkYshY5p_fqWat9DTsV1CTd0jbewIab7MKLQXWY_hbc5bppgKxZv8nUE0SFZND90R8OfpJzF4qu5-OcfCPL8WyRk3wx8xrHoFIClyexgXQAg1yooLchUpBx6DqZIi7X9-9g2Dv78_08qm5diCzjTIQGtdgkjDlmueWKeWulEUZTYaShXFNMdkbqTHPluIh17BP8CJMyS4yUvmPYHjQm04nbB-Ksy4Tg1slMJah6qTX6vNXWOOo6XDXh82rzU1tRkoebMW7SkkyZprhtabFtTTipRe9KHo5_CR2uNJhWrpinDEFlCAXtpAnH9Wt0onAyoiduuihkWMA-kjbhfan5eham0LZEEuNiCwU_PX36a3BVPBz8v-gHeEkRJpUFwIfQmM8W7iNs2yWqdXYEm2Ikjyq7fgDhK_tc |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LbxMxEB6VFAEX3pRAAYM4cNl240dsS1zKI6SwG1WoqXpb2V5bCmqTKmki9d93vLvZqAIkJG4reSxbHs_Mt_bMZ4D3ZRlKEWLplrYy4X1lEpsKn9C-Db1QYkisUv5PMjkaqdNTfbQFH9e1MDU_RHvgFi2j8tfRwOOB9P6GNfTX-WqPatWTt2Cb4zYSHdj-8nMwzlpPrHR9i4DeIME4JNbMQindbzvfjEe_gcybmLUKOoMH_zfdh3C_AZvkoN4dj2DLTx_Dnby5Tn8C_mhTNkA2vN9kFgjiQpIffMvG-SEZ-ph2fTlZkE9kNZkvF2SxnAeDfVAtkc2TuEg7gG4u5tC76CvIJNadzBCZm6unMB58Pf48TJp3FxLHBJOxRC21nDHPnHBCs-CcstIaKq2yVBiK4c4qUxqhvZCpSQPH3zClSm6VCn3LnkFnOpv650C886WUwnlVao7KV8ag1TvjrKe-L3QXPqxXv3ANKXl8G-OsqOmUaYHLVlTL1oV3rehFzcTxJ6HdtQqLxhgXBUNYGZ1Bj3fhbduMZhTvRszUz5aVDIvoR9Eu7NSqb0dhOmVc8hQnW2n478MX3_OT6uPFv4u-gbvD4zwrssPRj5dwjyJoqtOBd6FzOV_6V3DbrVDF89fN9r4G-67-ZA |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3daxNBEB9qK8UX67exVVfxwZezl_243QVfamtsNQlBTOnbsZ8Q0aQkTcD_3tm7y4VSBcG3g5tll52dmd_dzPwW4I330YuYWre0lRkvlMlsLkJGCxu70WNIrEr-z_tyOFQXF3q0Be_XvTA1P0T7wy1ZRuWvk4GHSx8PN6yh33-u3lGtuvIW7HChCzTLnZOvvXG_9cRK11kE9AYZxiGxZhbK6WE7-Ho8ugEyr2PWKuj09v5vuffgbgM2yVF9Ou7DVpg-gN1Bk05_CGG0aRsgG95vMosEcSEZHH3qjwdn5DSksuuryYJ8IKvJfLkgi-U8GhyDaklsnsQl2gF0c6mG3iVfQSap72SGyNz8egTj3sdvx6dZc-9C5phgMrWo5ZYzFpgTTmgWnVNWWkOlVZYKQzHcWWW8EToImZs8cvwMU8pzq1QsLHsM29PZNDwFElzwUgoXlNccla-MQat3xtlAQyF0B96ud790DSl5uhvjR1nTKdMSt62stq0Dr1vRy5qJ409CB2sVlo0xLkqGsDI5gy7vwKv2NZpRyo2YaZgtKxmW0I-iHXhSq76dhemccclzXGyl4b9PX34enFcPz_5d9CXsjk56Zf9s-GUf7lDETHU18AFsX82X4TncdivU8PxFc7p_A4oU_d8 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Performance+evaluation+of+the+MAGLUMI+Hepatitis+B+virus+surface+antigen+chemiluminescence+immunoassay&rft.jtitle=Journal+of+medical+virology&rft.au=Shen%2C+Lihong&rft.au=Zhang%2C+Yun&rft.au=Shi%2C+Min&rft.au=Shao%2C+Lijia&rft.date=2024-07-01&rft.issn=1096-9071&rft.eissn=1096-9071&rft.volume=96&rft.issue=7&rft.spage=e29817&rft_id=info:doi/10.1002%2Fjmv.29817&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0146-6615&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0146-6615&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0146-6615&client=summon |